Clinical Trial Update: The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

The trial evaluated melatonin for depression, anxiety, cognitive function, and sleep disturbances in breast cancer patients across phase 2/3, but it was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Major Depressive Disorder

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Melissa Voigt Hansen | Conditions: Breast Cancer, Depression | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-05-06